SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-15-001147
Filing Date
2015-02-13
Accepted
2015-02-13 16:51:29
Documents
11
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nbio_10q.htm 10-Q 124542
2 CERTIFICATION nbio_ex311.htm EX-31.1 9803
3 CERTIFICATION nbio_ex312.htm EX-31.2 10003
4 CERTIFICATION nbio_ex321.htm EX-32.1 3548
5 CERTIFICATION nbio_ex322.htm EX-32.2 3238
  Complete submission text file 0001477932-15-001147.txt   1438320

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nbio-20141231.xml EX-101.INS 113587
7 XBRL TAXONOMY EXTENSION SCHEMA nbio-20141231.xsd EX-101.SCH 20942
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbio-20141231_cal.xml EX-101.CAL 28508
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbio-20141231_def.xml EX-101.DEF 29934
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbio-20141231_lab.xml EX-101.LAB 108662
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbio-20141231_pre.xml EX-101.PRE 87272
Mailing Address 8400 MIRAMAR ROAD SUITE 247 SAN DIEGO CA 92126
Business Address 8400 MIRAMAR ROAD SUITE 247 SAN DIEGO CA 92126 612-961-5656
Nascent Biotech Inc. (Filer) CIK: 0001622057 (see all company filings)

IRS No.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-55299 | Film No.: 15615722
SIC: 2834 Pharmaceutical Preparations